StonvexLoading…
StonvexStonvexStonvexCore line items from BNTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €2.87B | €2.75B | €3.82B | €17.31B |
Operating Income | €-1.40B | €-1.31B | €690.40M | €12.64B |
Net Income | €-1.14B | €-665.30M | €930.30M | €9.43B |
EPS (Diluted) | €-4.70 | €-2.77 | €3.83 | €37.77 |
Total Assets | €21.99B | €22.53B | €23.01B | €23.28B |
Total Liabilities | €2.76B | €3.12B | €2.76B | €3.22B |
Cash & Equivalents | €7.68B | €9.76B | €11.66B | €13.88B |
Free Cash Flow OCF − CapEx | €280.90M | €-78.80M | €5.12B | €13.25B |
Shares Outstanding | 251.33M | 239.97M | 237.73M | 243.22M |